Mannkind reported $384.54M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Adma Biologics ADMA:US $ 138.42M 43.56M
Biocryst Pharmaceuticals BCRX:US $ 622.18M 17.72M
Chemocentryx CCXI:US $ 23.68M 0.05M
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Eli Lilly And LLY:US $ 16813.8M 305M
Halozyme Therapeutics HALO:US $ 877.64M 0.97M
Insmed INSM:US $ 807.32M 534K
JAZZ PHA JAZZ:US $ 6021M 2.87M
Karyopharm Therapeutics KPTI:US $ 302.69M 202K
Macrogenics MGNX:US $ 0M 0M
Mannkind MNKD:US $ 384.54M 2.84M
Minerva Neurosciences NERV:US $ 0M 0M
Novavax NVAX:US $ 440.5M 13.49M
Novo Nordisk A Fs NVO:US $ 25434M 46M
Peregrine Pharmaceuticals PPHM:US $ 142.18M 0.14M
Xencor XNCR:US $ 0M 0M